JP2016117752A - 骨強化促進用組成物 - Google Patents
骨強化促進用組成物 Download PDFInfo
- Publication number
- JP2016117752A JP2016117752A JP2016039254A JP2016039254A JP2016117752A JP 2016117752 A JP2016117752 A JP 2016117752A JP 2016039254 A JP2016039254 A JP 2016039254A JP 2016039254 A JP2016039254 A JP 2016039254A JP 2016117752 A JP2016117752 A JP 2016117752A
- Authority
- JP
- Japan
- Prior art keywords
- calcium
- maltobionate
- bone
- composition
- strengthening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000005728 strengthening Methods 0.000 title claims abstract description 42
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 230000001133 acceleration Effects 0.000 title abstract 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000011575 calcium Substances 0.000 claims abstract description 66
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 66
- JYTUSYBCFIZPBE-ZNLUKOTNSA-N cellobionic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-ZNLUKOTNSA-N 0.000 claims abstract description 33
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims abstract description 6
- 150000002596 lactones Chemical class 0.000 claims abstract description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims abstract description 4
- 239000011734 sodium Substances 0.000 claims abstract description 4
- 229910052708 sodium Inorganic materials 0.000 claims abstract description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims abstract description 3
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims abstract description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052802 copper Inorganic materials 0.000 claims abstract description 3
- 239000010949 copper Substances 0.000 claims abstract description 3
- 229910052742 iron Inorganic materials 0.000 claims abstract description 3
- 239000011777 magnesium Substances 0.000 claims abstract description 3
- 229910052749 magnesium Inorganic materials 0.000 claims abstract description 3
- 239000011591 potassium Substances 0.000 claims abstract description 3
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 3
- 239000011701 zinc Substances 0.000 claims abstract description 3
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 3
- 210000000988 bone and bone Anatomy 0.000 claims description 58
- 230000001737 promoting effect Effects 0.000 claims description 29
- JYTUSYBCFIZPBE-QOKIMYEXSA-N (2r,3r,4r,5r)-2,3,5,6-tetrahydroxy-4-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexanoic acid Chemical compound OC(=O)[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JYTUSYBCFIZPBE-QOKIMYEXSA-N 0.000 claims description 18
- JYTUSYBCFIZPBE-UHFFFAOYSA-N Maltobionic acid Natural products OC(=O)C(O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O JYTUSYBCFIZPBE-UHFFFAOYSA-N 0.000 claims description 16
- 235000013305 food Nutrition 0.000 claims description 8
- 230000008021 deposition Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 abstract 1
- 229950006191 gluconic acid Drugs 0.000 abstract 1
- 235000012208 gluconic acid Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 62
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 14
- 239000007788 liquid Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 230000037396 body weight Effects 0.000 description 7
- 229910000019 calcium carbonate Inorganic materials 0.000 description 7
- 208000001132 Osteoporosis Diseases 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 210000000689 upper leg Anatomy 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 230000037182 bone density Effects 0.000 description 4
- 210000002805 bone matrix Anatomy 0.000 description 4
- 238000009395 breeding Methods 0.000 description 4
- 230000001488 breeding effect Effects 0.000 description 4
- 235000012631 food intake Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 210000002997 osteoclast Anatomy 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 241000700159 Rattus Species 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000000963 osteoblast Anatomy 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 240000007124 Brassica oleracea Species 0.000 description 2
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 235000015170 shellfish Nutrition 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 235000019786 weight gain Nutrition 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 235000001169 Brassica oleracea var oleracea Nutrition 0.000 description 1
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- FSICMNGKCHFHGP-QOKIMYEXSA-N D-maltobiono-1,5-lactone Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(=O)[C@H](O)[C@H]1O FSICMNGKCHFHGP-QOKIMYEXSA-N 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 206010021033 Hypomenorrhoea Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 108010001441 Phosphopeptides Proteins 0.000 description 1
- 240000004713 Pisum sativum Species 0.000 description 1
- 235000010582 Pisum sativum Nutrition 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 238000004380 ashing Methods 0.000 description 1
- 235000021053 average weight gain Nutrition 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 235000015895 biscuits Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 1
- 239000001639 calcium acetate Substances 0.000 description 1
- 235000011092 calcium acetate Nutrition 0.000 description 1
- 229960005147 calcium acetate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- 235000010376 calcium ascorbate Nutrition 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 230000003185 calcium uptake Effects 0.000 description 1
- BLORRZQTHNGFTI-ZZMNMWMASA-L calcium-L-ascorbate Chemical compound [Ca+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] BLORRZQTHNGFTI-ZZMNMWMASA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000037319 collagen production Effects 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000012847 fine chemical Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- -1 granular Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000012431 wafers Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
骨芽細胞は、骨基質であるコラーゲン細繊維をつくり、ここへ血中から取り込んだカルシウムを沈着させることで、硬いが弾力のある骨基質が形成される。一方、破骨細胞は、骨を壊す細胞であり、古い骨のカルシウムやコラーゲンを酸や酵素で溶かし、溶けたカルシウムは血管を通り体内へと運ばれていく。
血中のカルシウムの濃度は、8.4〜10.2mg/dL程度の範囲に保たれており、食事等などより摂取したカルシウムは、腸管から吸収され血中に入るが、血中のカルシウム濃度が上昇すると、甲状腺からカルシトニンの分泌が増大し、腸管からのカルシウム吸収を抑制すると共に、肝臓からのカルシウムの排出を促進し、速やかに尿などと一緒に体外に運び出される。
このため、骨強化するためには、血中のカルシウム濃度を一時的に高めるだけではなく、その血中カルシウムを速やかかつ破骨よりも優勢に骨へ沈着させることが重要となる。
本発明の骨強化促進用組成物は、有効成分として、マルトビオン酸、その塩又はマルトビオノデルタラクトンが、骨芽細胞を活性させ、コラーゲンの産生を促進することで、カルシウムの取り込みを増大させる共に、破骨細胞による過剰な骨破壊を抑制したことにより、骨中のカルシウム含有量を増大させたものと推測される。
30%マルトース溶液(和光純薬製)1000mLに、5%パラジウム炭素触媒(川研ファインケミカル製)を9g添加した。この溶液を40℃に保持した後、空気1.0L/min、回転数600rpmで反応を開始させた。反応pHは9.0に維持するように20%水酸化ナトリウム溶液を連続的に添加した。反応6時間後、触媒を含む反応液を遠心分離と0.2μmのメンブレンフィルターでろ過し、マルトビオン酸ナトリウム溶液を得た。この溶液を強酸性カチオン交換樹脂(ダウケミカル社製、商品名「DOWEX−88」)2Lをつめたカラムへ通液することで脱塩処理を行った。次に、弱塩基性アニオン交換樹脂(三菱化学社製、商品名「WA30」)200mLと強酸性カチオン交換樹脂(ダウケミカル社製、商品名「DOWEX−88」)200mLの混合樹脂をつめたカラム、次いで粒状活性炭(武田薬品工業製、粒状白鷺)200mLをつめたカラムに順次通液し脱色を行った後、減圧濃縮によりマルトビオン酸濃度40%まで濃縮した。これに炭酸カルシウムを添加しつつ、撹拌溶解させることでマルトビオン酸カルシウム塩を調製した。溶液のpHが7.0に達したところで反応を終了とし、この溶液を0.2μmフィルターで濾過し、凍結乾燥することで、マルトビオン酸カルシウム粉末サンプルを得た。
AIN−76(商標)飼料組成を一部改変し、カルシウム源として、マルトビオン酸カルシウムと炭酸カルシウムを組み合わせ、それぞれカルシウム含有量が同じになるように飼料を調製した。カルシウム源が炭酸カルシウムのみの比較例1(コントロール群)および、炭酸カルシウムのカルシウム量をそれぞれ25%、50%、100%置き換えた実施例1(マルトビオン酸カルシウム25%群)、実施例2(マルトビオン酸カルシウム50%群)、実施例3(マルトビオン酸カルシウム100%群)の計4つの群を設けた。また、各飼料のカルシウム量は標準飼料の50%量(カルシウム含有量257mg/100g飼料)とした。
試験動物として6週齢のWistar系ST/Clean雄ラット(日本SLC社)を用いた。
ラット(28匹)はステンレス製個別ゲージに入れ、実験環境に慣らすために7日間、AIN−76標準飼料を用いて予備飼育を行い、各実験群の平均体重が等しくなるように群分け(n=7)を行い、28日間本飼育を行った。飼育室の温度は、23±1℃、明暗12時間サイクル(明期8:00〜20:00)とした。試験期間中の体重および飼料摂取量は毎日測定した。なお各群のカルシウム摂取量を合わせるためにペアフィーデングを行い、飲料水はイオン交換水を与え自由摂水とした。本飼育開始後29日目にラットをと殺し、大腿骨を膝関節部と骨盤ヒンジ骨より脱離骨膜を剥離した後、110℃で15時間乾燥させた後、重量およびノギスで骨長を測定した。
乾燥させた右大腿骨を食品用ミルサーで粉末化後、0.1gをテフロン(登録商標)ビーカーに秤りとり、濃硝酸11mL、70%過塩素酸10mL、6N塩酸7mLをそれぞれ加え、ホットプレートにて120℃、390分間加熱し湿式灰化した。これを試料液として、カルシウム量を比色法(OCPC法)にて定量した。
結果はすべて平均値±標準誤差で表し、一元配置の分散分析後、各群間での有意差検定にはScheffeの方法を用い、危険率5%にて有意差を判定した。表記は同じアルファベット記号を持たない群間にP<0.05にて有意差があることを示している。
飼育期間中、毎日測定した体重と摂食量に基づき、各群における終体重、平均体重増加量、平均摂食量、平均食餌効率(平均体重増加量÷平均摂食量)を表2に示した。各項目ともに群間に差は確認されなかった。
骨塩量の指標となる大腿骨のカルシウム量を、大腿骨1本あたりおよび大腿骨1g当たりとして表3に示した。比較例に比べ,実施例では、有意なカルシウムの増加が確認された。この結果から,マルトビオン酸カルシウムを摂取することより効率的にカルシウムの吸収を行い,吸収されたカルシウムは骨形成まで行われていることが示された。
Claims (3)
- 4−O−α−D−グルコピラノシル−D−グルコン酸の一般式で表されるマルトビオン酸、その塩類およびそのラクトンからなる群から選択される少なくとも1つ以上を含み、かつカルシウム成分を含む骨強化促進用組成物。
- 前記塩類が、マルトビオン酸ナトリウム、マルトビオン酸カルシウム、マルトビオン酸マグネシウム、マルトビオン酸カリウム、マルトビオン酸銅、マルトビオン酸鉄およびマルトビオン酸亜鉛から選択される少なくとも1つ以上である、請求項1記載の骨強化促進用組成物。
- 飲食品組成物である請求項1又は2記載の骨強化促進用組成物。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016039254A JP6692183B2 (ja) | 2016-03-01 | 2016-03-01 | 骨強化促進用組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016039254A JP6692183B2 (ja) | 2016-03-01 | 2016-03-01 | 骨強化促進用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016117752A true JP2016117752A (ja) | 2016-06-30 |
| JP6692183B2 JP6692183B2 (ja) | 2020-05-13 |
Family
ID=56242815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016039254A Active JP6692183B2 (ja) | 2016-03-01 | 2016-03-01 | 骨強化促進用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6692183B2 (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022087490A (ja) * | 2020-12-01 | 2022-06-13 | サンエイ糖化株式会社 | コラーゲン類吸収促進剤及びコラーゲン類の吸収を促進する方法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009143883A (ja) * | 2007-12-18 | 2009-07-02 | San-Ei Sucrochemical Co Ltd | マルトビオン酸、その塩又はマルトビオノデルタラクトン含有組成物の用途 |
-
2016
- 2016-03-01 JP JP2016039254A patent/JP6692183B2/ja active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009143883A (ja) * | 2007-12-18 | 2009-07-02 | San-Ei Sucrochemical Co Ltd | マルトビオン酸、その塩又はマルトビオノデルタラクトン含有組成物の用途 |
Non-Patent Citations (1)
| Title |
|---|
| 日本食物繊維学会誌, vol. 13, no. 2, JPN6019043763, 2009, pages 145, ISSN: 0004151551 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022087490A (ja) * | 2020-12-01 | 2022-06-13 | サンエイ糖化株式会社 | コラーゲン類吸収促進剤及びコラーゲン類の吸収を促進する方法 |
| JP7627109B2 (ja) | 2020-12-01 | 2025-02-05 | サンエイ糖化株式会社 | コラーゲン類吸収促進剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JP6692183B2 (ja) | 2020-05-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4702745B2 (ja) | ミネラル吸収促進剤及びその用途 | |
| JP5465834B2 (ja) | 肝機能保護剤 | |
| CN101674839A (zh) | 制备含骨钙素提取物的方法 | |
| CN101496576A (zh) | 一种供骨伤患者食用含短肽的特殊膳食用食品配方 | |
| CN118901801A (zh) | 促进骨骼成长的有机钙配方奶粉的制备方法、产品及应用 | |
| JP5281895B2 (ja) | カルシウム吸収促進剤 | |
| JPWO2009057287A1 (ja) | 破骨細胞形成抑制用食品素材 | |
| JP4526047B2 (ja) | 体力増強剤 | |
| JP5586713B2 (ja) | ミネラル可溶化安定剤 | |
| JP5077982B2 (ja) | 脂肪蓄積抑制剤 | |
| JP6692183B2 (ja) | 骨強化促進用組成物 | |
| CN119214189A (zh) | 一种儿童调制乳粉及其制备方法和应用 | |
| JP2004115509A (ja) | 破骨細胞分化抑制因子産生促進剤 | |
| JP2007022989A (ja) | 抗疲労剤 | |
| JP5628355B2 (ja) | ミネラル吸収促進剤及び易吸収性カルシウム剤 | |
| KR101306931B1 (ko) | 골다공증 예방 효과를 가지는 유기태화 칼슘 강화 유단백질 | |
| Jung et al. | 17 Calcium from Fish Bone and Other Marine Resources | |
| JP6279851B2 (ja) | 筋萎縮防止及び/又は筋合成促進剤 | |
| JP4493736B2 (ja) | キチンを含有するミネラル吸収促進性組成物およびミネラル吸収促進用添加剤 | |
| JP6395350B2 (ja) | 筋萎縮防止剤 | |
| JP2010095474A (ja) | カルシウム吸収促進組成物及びカルシウム吸収促進飲食物 | |
| JP5371415B2 (ja) | 骨密度減少抑制組成物 | |
| CN109938354A (zh) | 一种用于增强钙吸收的营养组合物及其应用方法 | |
| JP4111429B2 (ja) | 骨粗鬆症予防剤又は治療剤 | |
| JP4659405B2 (ja) | 骨形成促進剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20160317 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190121 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20191016 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20191112 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20200109 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200331 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200414 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 6692183 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
